The evidence, the treatment formats and the real cost of care. A clear starting point for your next conversation with a clinician.
Trial findings apply to the studied branded injections—not compounded products, oral Wegovy or Wegovy HD. Individual results vary.
Average reduction in starting body weight
751 adults with obesity, without type 2 diabetes. Weekly injections: tirzepatide 10/15 mg vs semaglutide 1.7/2.4 mg, maximum tolerated doses. Diet and activity counseling in both groups.
Randomized, open-label; funded by Eli Lilly. Read the study & limitations ↗
Seven care and fulfillment pathways for comparing semaglutide and tirzepatide access. Read the medicine type, plan term and complete cost; CoreAge Rx appears first through disclosed commercial placement.
An online care service advertising compounded semaglutide and tirzepatide with supplies and shipping.
Compounded medications are not FDA-approved.
A membership model with FDA-approved medication options and insurance-support services.
Care fee and medication are separate charges.
Weight-loss care with a separate membership and medication bill, including oral and injectable options.
Paying a membership fee does not guarantee a prescription.
Clinical and nutrition support with medication charges separate from the membership.
The lowest medication quote is not a complete monthly total.
A route to prescribed Zepbound through manufacturer-supported pharmacy fulfillment.
Medication fulfillment is different from a bundled care membership.
Separate starter, transfer and monthly plans for semaglutide and tirzepatide.
An ingredient comparison does not establish equivalence of finished products.
Med+ supports access to approved medicines with separate membership and drug charges.
Ongoing membership and medication must both be included in the budget.
A publisher-priced compounded semaglutide program from $79 per month. Identify the dispensed preparation and selected plan before comparing it with branded Wegovy.
The publisher lists CoreAge Rx compounded tirzepatide from $129 per month. The ingredient’s branded trial evidence does not establish the performance of this preparation.
An approved semaglutide injection accessed through Ro’s care membership. The medication, selected dose and membership are separate parts of the decision.
Branded tirzepatide paired with Ro’s clinical membership. Confirm the delivery format, medication price and care fee before comparing it with compounded or manufacturer-direct offers.
Daily oral semaglutide within a required Hers membership. It is an approved tablet product with its own instructions, and it was not the semaglutide formulation tested in SURMOUNT-5.
A multi-dose, single-patient-use tirzepatide pen paired with the Hers membership. It differs from both a single-dose Zepbound pen and a compounded vial.
A dose-dependent compounded injection offer with membership billed separately. The initial medication price does not establish the ongoing total or equivalence to Wegovy.
Mochi advertises compounded tirzepatide as low as $90, plus membership, with dose-dependent pricing. Read that as a starting offer for a distinct preparation.
A branded tirzepatide vial fulfilled through LillyDirect’s self-pay pathway. The dose-specific price, injection supplies and separate prescribing relationship all matter.
A single-patient-use pen containing four weekly doses of branded tirzepatide. Compare its supplies and dose-specific program terms with the vial and single-dose pen.
The starter, transfer and standard charges behind this provider’s tirzepatide offer, with the finished-product distinction kept visible.
A review of the membership around the medicine: term commitment, clinical access, insurance assistance and behavioral support.
How to compare records, prescriptions, pharmacy arrangements and costs without treating a commercial transfer offer as a dosing plan.
Why self-reported member results, engagement statistics and randomized drug trials answer different questions.
Tirzepatide produced a larger average weight reduction than the studied semaglutide regimen. The population, doses and analysis define how far that finding can travel.
The medicines act on related pathways, but the molecule, finished product, indication and delivery format all matter.
We read product pages, published research, and regulatory guidance. We explain the tradeoffs, distinguish marketing from evidence, and link the sources so you can look closer.
Read our methodology